May 13th 2025
Covered California and Health Net’s novel data exchange initiative significantly improved quality measurement and potentially reduced costs by more than $640,000.
Obamacare Question: Ditch Employer Mandate?
May 12th 2014A left-leaning think tank whose research is often taken seriously by backers of the health-care overhaul has published a paper suggesting the administration should scrap the health law's requirement that employers offer coverage or pay a penalty.
Read More
Editor Shares Practical Road Map Through Maze of Therapy Options
May 7th 2014Attendees at the 167th Annual Meeting of the American Psychiatric Association (APA), convening at the Jacob K. Javits Center in New York City, appreciated Sunday's opportunity to hash out practical day-to-day issues at Meet the Author: Evidence-Based Guide to Antidepressant Medications and Antipsychotic Medications, with editor Anthony J. Rothschild, MD, director of the Center for Psychopharmacologic Research and Treatment, at University of Massachusetts Medical School.
Read More
Limited Medicare ACO Quality Data Show Sharp Variations in Performance
May 7th 2014Since the Obama administration launched its accountable care initiative as part of healthcare reform in 2012, the CMS has announced which hospital and physician networks in one of the programs have met cost targets and received shared savings. But so far, it has published little data on quality of care delivered by these networks, which were designed to deliver better care as well as lower costs for Medicare patients.
Read More
CMS Data Shows That Elderly Health Spending Slowed Between 2002-2010
May 6th 2014The Centers for Medicare & Medicaid Services (CMS) reported that between 2002 and 2010, elderly healthcare spending grew at the slowest rate among all age groups, which, according to CMS, can be attributed to the recession.
Read More
Anthony Rothschild, MD, Discusses How Healthcare Barriers Can Keep Patients From Antipsychotics
May 6th 2014Anthony J. Rothschild, MD, says that barriers to expensive antipsychotic drugs are shortsighted. He adds that the American Psychiatric Association, in accordance with some in Congress, recently rejected a CMS decision that would have restricted the number of antidepressants and antipsychotics Medicare beneficiaries could receive.
Watch
Affordable Drug Choices More Limited in Medicare, Study Finds
April 29th 2014The American Journal of Managed Care publishes a first-of-its-kind study comparing different types of health insurance plans and different levels of co-payment, to see how varieties of coverage affect access to therapeutic drug classes.
Read More